Status:
COMPLETED
Comparative Effectiveness of Oral Anticoagulants
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
This cohort study plans to identify initiators of oral anticoagulants using electronic claims data from a commercial insurance database to quantify associations between anticoagulant choice (warfarin ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- A recorded diagnosis of atrial fibrillation (AF).
- Initiation of anticoagulant medication (dabigatran or warfarin).
- At least 18 years of age on the date of anticoagulant initiation CHA2DS2-VASc-Score \>=1
- Exclusion criteria:
- Patients with missing or ambiguous age or sex information
- Patients with documented evidence of valvular disease
- Patients with less than 12 months enrolment in the UnitedHealth Research Database preceding the date of anticoagulant initiation
- Patients with prior use of any oral anticoagulant
Exclusion
Key Trial Info
Start Date :
April 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
5982 Patients enrolled
Trial Details
Trial ID
NCT01847547
Start Date
April 1 2013
End Date
April 1 2013
Last Update
June 6 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.